CanSino Biologics Inc. (SHA:688185)

CanSino Biologics Statistics

Total Valuation

SHA:688185 has a market cap or net worth of CNY 16.41 billion. The enterprise value is 15.02 billion.

Market Cap	16.41B
Enterprise Value	15.02B

Important Dates

The last earnings date was Thursday, August 21, 2025.

Earnings Date	Aug 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	114.78M
Shares Outstanding	n/a
Shares Change (YoY)	+4.65%
Shares Change (QoQ)	+33.61%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	159.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	123.36
PS Ratio	17.74
PB Ratio	3.35
P/TBV Ratio	3.49
P/FCF Ratio	n/a
P/OCF Ratio	281.84
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-89.95
EV / Sales	16.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-55.48

Financial Position

The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.39.

Current Ratio	2.57
Quick Ratio	2.32
Debt / Equity	0.39
Debt / EBITDA	n/a
Debt / FCF	-6.98
Interest Coverage	-4.73

Financial Efficiency

Return on equity (ROE) is -3.35% and return on invested capital (ROIC) is -2.21%.

Return on Equity (ROE)	-3.35%
Return on Assets (ROA)	-1.96%
Return on Invested Capital (ROIC)	-2.21%
Return on Capital Employed (ROCE)	-4.13%
Revenue Per Employee	829,809
Profits Per Employee	-149,772
Employee Count	1,105
Asset Turnover	0.12
Inventory Turnover	0.67

Taxes

Income Tax	-4.32M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +136.06% in the last 52 weeks. The beta is 1.10, so SHA:688185's price volatility has been similar to the market average.

Beta (5Y)	1.10
52-Week Price Change	+136.06%
50-Day Moving Average	71.09
200-Day Moving Average	63.14
Relative Strength Index (RSI)	69.43
Average Volume (20 Days)	4,513,596

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688185 had revenue of CNY 925.24 million and -167.00 million in losses. Loss per share was -0.65.

Revenue	925.24M
Gross Profit	689.68M
Operating Income	-248.57M
Pretax Income	-171.31M
Net Income	-167.00M
EBITDA	-91.07M
EBIT	-248.57M
Loss Per Share	-0.65

Balance Sheet

The company has 3.27 billion in cash and 1.89 billion in debt, giving a net cash position of 1.38 billion.

Cash & Cash Equivalents	3.27B
Total Debt	1.89B
Net Cash	1.38B
Net Cash Per Share	n/a
Equity (Book Value)	4.90B
Book Value Per Share	19.82
Working Capital	2.65B

Cash Flow

In the last 12 months, operating cash flow was 58.23 million and capital expenditures -328.98 million, giving a free cash flow of -270.75 million.

Operating Cash Flow	58.23M
Capital Expenditures	-328.98M
Free Cash Flow	-270.75M
FCF Per Share	n/a

Margins

Gross margin is 74.54%, with operating and profit margins of -26.87% and -18.05%.

Gross Margin	74.54%
Operating Margin	-26.87%
Pretax Margin	-18.52%
Profit Margin	-18.05%
EBITDA Margin	-9.84%
EBIT Margin	-26.87%
FCF Margin	n/a

Dividends & Yields

SHA:688185 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.65%
Shareholder Yield	-4.65%
Earnings Yield	-1.02%
FCF Yield	-1.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHA:688185 has an Altman Z-Score of 2.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.18
Piotroski F-Score	6